250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care VC (Venture Capital) Funds in Asia in January 2025

A list of 50 VC (Venture Capital) funds that invest in Health care startups based in Asia. We rank investors based on the number of investments they made in Health care companies from Asia. We update this investor list every month.

Top 50 Health Care VC (Venture Capital) Funds in Asia in January 2025

Investor Health Care Asia investments
Qiming Venture Partners 68
BioVenture 56
HongShan 53
Med-Fine Capital 45
Matrix Partners China 37
Lilly Asia Ventures 37
Legend Capital 33
Highlight Capital 32
IDG Capital 32
Mitsubishi UFJ Capital 29
Puhua Capital 29
Frees Fund 29
Kaitai Capital 29
Seeds Capital 29
Legend Star 27
BioTrack Capital 27
Northern Light Venture Capital 26
UntroD Capital 26
SMBC Venture Capital 26
CD Capital 26
ANRI 25
Marathon Venture Partners 24
Cowin Capital 24
Share Capital 23
Dalton Venture 23
CDH Investments 22
East Ventures 21
Cowin Venture 21
TF Capital 21
Prox Ventures 21
Huagai Capital 20
UTEC - The University of Tokyo Edge Capital Partners 20
Hillhouse Investment 19
Sinopharm Capital 19
Sherpa Healthcare Partners 19
Volcanics Venture 19
Oriza Holdings 19
Nissay Capital 19
Nippon Venture Capital 18
CASH Capital 18
Gaorong Capital 18
Osaka University Venture Capital 17
Shenzhen Capital Group 17
Sinovation Ventures 17
Plum Ventures 17
Lenovo Capital and Incubator Group (LCIG) 16
ZhenFund 16
LYFE Capital 16
Keio Innovation Initiative 16
Oriental Fortune Capital 15
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 31 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • StepStar — The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like
  • Zhipu AI — Zhipu AI is a data company developing an AI-based large model platform to provide API services. It includes a variety of smart application products such as the scientific and technological information analysis engine and AI cognitive engines to allow users to leverage AI-powered tools to reduce manual labor in digital tasks.
  • XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
BioVenture VC Fund · Suzhou, Jiangsu, China · 8 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
HongShan VC Fund · Beijing, Beijing, China · 32 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • SoSoValue — SoSoValue is a groundbreaking technology that changes the way investors access and evaluate cryptocurrency data. The company intends to level the playing field by ensuring equal access to cutting-edge data technology and insights. SoSoValue leverages strong AI capabilities to provide extensive research tools, real-time data, and a thrivingcommunity for collaborative growth.
  • Kast — Kast Finance provides open access, financial freedom, and rapid gratification services.
  • GCL Optoelectronics — GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 5 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
  • Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Matrix Partners China VC Fund · Beijing, Beijing, China · 19 investments in the past 12 months
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
  • Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
  • Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 14 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Syneron — Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals.
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
Legend Capital VC Fund · Beijing, Beijing, China · 17 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
  • Chuangrui Spectrum — Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.
  • TBSTest Technology — Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 8 investments in the past 12 months
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
  • Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
  • ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
IDG Capital VC Fund · Beijing, Beijing, China · 19 investments in the past 12 months
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
  • ChainOpera AI — ChainOpera AI - The Blockchain and Protocol for Co-owning and Co-creating Decentralized AI Apps and Agents for Humanity, Backed by Federated AI OS and Platform
  • Yin Gong Technology — Yin Gong Technology develops energy storage technology. It is an innovative battery technology developer in the green technology field.
Mitsubishi UFJ Capital VC Fund · Tokyo, Tokyo, Japan · 65 investments in the past 12 months
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Funding Round, Series A, Series B
  • Japan, United States, China
Portfolio highlights
  • Taian — Taian, which specializes in bridal industry services and software. They also provide ''Concept Marry,'' which allows couples to design invites and seating charts that match their wedding theme, as well as display guest information on Oiwaii.
  • greenase — greenase is a manufacturer and seller of processed agricultural products.
  • Grand Central — Grand Central is a consulting company specializing in the sales field.
Puhua Capital VC Fund · Hangzhou, Zhejiang, China · 12 investments in the past 12 months
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
  • Health Care, Medical, Manufacturing
  • Series A, Series B, Seed
  • China, United Kingdom, United States
Portfolio highlights
  • DeepWay — DeepWay is a maker and developer of intelligent electric commercial vehicles.
  • Aptech — Aptech is a creative firm focused on cutting-edge biotechnology, with a strong scientific research foundation from first-rate domestic scientific research institutions and substantial backing.
  • Dragonfly Wings — Dragonfly Wings is an eVTOL tilt-wing company that specializes in the development, R&D, production, and sales of tiltrotor eVTOL.
Frees Fund VC Fund · Beijing, Beijing, China · 13 investments in the past 12 months
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
  • Artificial Intelligence, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
  • Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
  • Molar Intelligence — Molar Intelligence is a professional artificial intelligence data service provider.
Kaitai Capital VC Fund · Hangzhou, Zhejiang, China · 2 investments in the past 12 months
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Angel, Series B
  • China, United States
Portfolio highlights
  • Xinyue — Yuejing Network Technology Co., Ltd. is a digital video assistant platform that cuts in the communication and review links in the video production stream, helping to achieve multi-platform preview of video demos in video production and convenient review comments and video storage. sort out. With the subsequent connection of external hardware, theuser can realize the real-time synchronization of the video data captured in the camera to the new cloud server, and later can synchronize production and storage sharing through the new reading.
  • Minova Pharma — Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.
  • TechnoDerma Medicines — TechnoDerma Medicines focuses on the research and development of innovative skin drugs for external use.
Seeds Capital VC Fund · Singapore, Central Region, Singapore · 11 investments in the past 12 months
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Funding Round
  • Singapore, United States, Hong Kong
Portfolio highlights
  • DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
  • Aevice Health — Meet our AeviceMD, all-in-one sensor to deliver hospital-quality insights, right from home.
  • Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
Legend Star VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Angel, Seed
  • China, United States, France
Portfolio highlights
  • CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
  • Pharos — Pharos incorporates effective blockchain technology into real-world asset verticals and decentralized finance. Pharos Network is promoting trustless innovations that benefit asset markets and underprivileged communities, bolstering the global economy of the future and facilitating the widespread use of Web3 technologies.
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
BioTrack Capital VC Fund · Shanghai, Shanghai, China · 5 investments in the past 12 months
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore
Portfolio highlights
  • Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
  • Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
  • Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 5 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
  • Tuliu.com — Tuliu.com is a comprehensive online platform for land transfers in China. The company integrates information like land area, prices, and development trends, forms an evaluation standard and provides farmers with free land value evaluation services.
  • weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.
UntroD Capital VC Fund · Sumida, Tokyo, Japan · 5 investments in the past 12 months
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
  • Manufacturing, Biotechnology, Robotics
  • Funding Round, Seed, Series A
  • Japan, Singapore, India
Portfolio highlights
  • Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
  • MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
  • Emulsion Flow Technologies — Emulsion Flow Technologies offers rare metal recycling, utilizing emulsion flow technology, emulsion.
SMBC Venture Capital VC Fund · Tokyo, Tokyo, Japan · 50 investments in the past 12 months
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more
Investment focus
  • Information Technology, Health Care, Software
  • Funding Round, Series B, Series A
  • Japan, United States, Singapore
Portfolio highlights
  • Striemo — Striemo manufactures and develops electric personal mobility. Striemo was founded in 2021 and was headquartered in Tokyo, Japan.
  • Orbital Lasers — Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data.
  • RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
CD Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
  • Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
ANRI VC Fund · Tokyo, Tokyo, Japan · 23 investments in the past 12 months
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more
Investment focus
  • Health Care, Information Technology, Software
  • Seed, Funding Round, Series A
  • Japan, United States, India
Portfolio highlights
  • Taian — Taian, which specializes in bridal industry services and software. They also provide ''Concept Marry,'' which allows couples to design invites and seating charts that match their wedding theme, as well as display guest information on Oiwaii.
  • ARCH — ARCH provides research, development, operation, and support systems for gynecology and fertility treatment solutions
  • Upsider — - Vue - Nuxt.js - TypeScript - SCSS
Marathon Venture Partners VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, Hong Kong, United States
Portfolio highlights
  • Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
  • Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
  • Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Cowin Capital VC Fund · Shenzhen, Guangdong, China · 20 investments in the past 12 months
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Series A, Series B, Angel
  • China, Hong Kong, United States
Portfolio highlights
  • Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
  • Zibo Xincai — Zibo Xincai is an integrated circuit manufacturing company that focuses on the development, manufacturing, and sales of core materials for semiconductor packaging.
  • Hengtuogao — Hitop Pneumatic Machinery specializes in the development, production, and distribution of pneumatic and electric actuators, grippers, and a wide range of components suitable for industrial automation. The company focuses on providing solutions that enhance efficiency and productivity in various industrial settings. With a commitment to innovationand quality, Hitop offers products designed to meet the diverse needs of its customers. The company's portfolio includes a comprehensive selection of automation machinery that caters to different sectors, ensuring that clients have access to the tools necessary for optimizing their operations.
Share Capital VC Fund · Shenzhen, Guangdong, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Colombia
Portfolio highlights
  • Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 15 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • India, China, Canada
Portfolio highlights
  • LegitQuest — An online legal research platform with Indian case laws. Research on Indian Cases, Judgments & Acts with AI enabled, User friendly product features.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
  • Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 21 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • Mianbi Smart — Mianbi Smart enables large-scale model acceleration and application execution using artificial intelligence.
  • Ultron Photonics — Altra Photonics is committed to developing the world's most advanced femtosecond laser systems, providing you with reliable and stable ultrafast lasers and various ultrafast laser machines, devices and application solutions to help you create higher value.
East Ventures VC Fund · Tokyo, Tokyo, Japan · 53 investments in the past 12 months
East Ventures is an early stage venture capital (VC) focused on Southeast Asia, Indonesia & Japan. Success cases include Tokopedia, Traveloka, and Mercari.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Funding Round
  • Japan, Indonesia, Singapore
Portfolio highlights
  • SoLeLands — SoLeLands provides children with future-ready skills, virtues, and applied competences and inspires children to love learning.
  • Maka Motors — MAKA is dedicated to building the best electric motorcycles for Indonesian riders.
  • Zenith Learning Group — Zenith Learning Group's mission is to deliver a holistic, world-class education to learners across South East Asia through technology.
Cowin Venture VC Fund · Beijing, Beijing, China · 6 investments in the past 12 months
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Angel, Series B
  • China, United States, Canada
Portfolio highlights
  • Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
  • Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
  • Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
TF Capital VC Fund · Pudong, Shandong, China · 2 investments in the past 12 months
TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
  • Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
Prox Ventures VC Fund · Shanghai, Shanghai, China
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • China, United States, United Kingdom
Portfolio highlights
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Huagai Capital VC Fund · Beijing, Beijing, China · 9 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Germany
Portfolio highlights
  • Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
  • ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
  • Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
UTEC - The University of Tokyo Edge Capital Partners VC Fund · Tokyo, Tokyo, Japan · 10 investments in the past 12 months
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Japan, United States, Singapore
Portfolio highlights
  • Estie — Estie is a Development of AI / machine learning algorithm and new business in real estate company.
  • Liminal — Advanced battery inspection and metrology with ultrasound and machine learning
  • Eureka Robotics — Eureka Robotics develop robotics technologies and products to automate the mundane, so that humans can focus on the creative.
Hillhouse Investment VC Fund · Changyang, Beijing, China · 9 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, Singapore
Portfolio highlights
  • dinii — Dinii is a mobile order platform for take-out shops.
  • Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Sinopharm Capital VC Fund · Shanghai, Shanghai, China
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Canada
Portfolio highlights
  • CytoNiche — CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
  • Metanovas Biotech — Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
  • Artivila Therapeutics — Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.
Sherpa Healthcare Partners VC Fund · Beijing, Beijing, China · 2 investments in the past 12 months
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya
Portfolio highlights
  • Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
  • Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Volcanics Venture VC Fund · Changning, Shanghai, China
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
  • Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Oriza Holdings VC Fund · Suzhou, Jiangsu, China · 11 investments in the past 12 months
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Jiongyi Electronics — Jiongyi Electronics is a developer of automotive brake products, focusing on the development of automotive brake product technology.
  • Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
  • Junhemeng Biopharmaceutical — Junhemeng is a research and development company of recombinant protein drugs.
Nissay Capital VC Fund · Tokyo, Tokyo, Japan · 23 investments in the past 12 months
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
  • Health Care, Internet, Medical
  • Funding Round, Seed, Series A
  • Japan, United States, Ethiopia
Portfolio highlights
  • Castee — Castee provides social collaboration services and also helps with a tool for job requests and overseas projects for creators.
  • HQ — HQ offers next-generation employee benefits platform.
  • Qlay — Qlay is an AI-automated global engineer hiring platform
Nippon Venture Capital VC Fund · Tokyo, Tokyo, Japan · 7 investments in the past 12 months
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Series A, Seed
  • Japan, United States
Portfolio highlights
  • Gecipe — Gecipe is a video service for e-sports players.
  • Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
  • Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
CASH Capital VC Fund · Beijing, Beijing, China
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Series A, Series B, Series C
  • China, United States
Portfolio highlights
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
  • Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
Gaorong Capital VC Fund · Wangjing, Beijing, China · 12 investments in the past 12 months
Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.
Show more
Investment focus
  • Information Technology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • China, United States, Hong Kong
Portfolio highlights
  • Ideaflow — Ideaflow is an AGI-era content technology firm focused on developing a new generation of content platforms powered by multimodal artificial intelligence. Its offering, the Dream Dimension app, is an interactive content platform that features a variety of stunning AI sceneries.
  • Zhongke Hydroyi — Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Osaka University Venture Capital VC Fund · Osaka, Osaka, Japan · 3 investments in the past 12 months
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Funding Round, Seed, Series A
  • Japan
Portfolio highlights
  • Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
  • Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
  • Red Arrow Therapeutics — Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
Shenzhen Capital Group VC Fund · Shenzhen, Guangdong, China · 27 investments in the past 12 months
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Supreium — Chuang Technology focuses on the research and application of computer-aided engineering and intelligent industrial design, independently develops the underlying algorithm solver, provides cloud-native intelligent cloud simulation and intelligent design services, and provides high-performance CAE algorithms, intelligent optimization algorithms andindustrial Software research and development and other fields have been at the international forefront.
  • Xinyao Semiconductor — Xinyao Semiconductor is a semiconductor materials company that specializes in the development of optoelectronics, lasers, and high-speed electronic devices. It is a subsidiary of Yunnan Germanium.
  • Tianjin Nankai Hecheng Technology Co. — Tianjin Nankai Hecheng Technology Co. is a biotechnology company that provides resin products.
Sinovation Ventures VC Fund · Beijing, Beijing, China · 9 investments in the past 12 months
Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.
Show more
Investment focus
  • Software, Artificial Intelligence, Internet
  • Series A, Seed, Series B
  • China, United States, Singapore
Portfolio highlights
  • Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
  • Anage Technology — Anage Technology is a software company focused on providing artificial intelligence-driven charging solutions for electric vehicles.
  • HPC-AI Technology — HPC-AI Technology provides a cloud-based platform to enhance AI computations by increasing CPU and GPU processing speeds.
Plum Ventures VC Fund · Changzhou, Zhejiang, China · 5 investments in the past 12 months
Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Series A, Angel, Seed
  • China, United States, Japan
Portfolio highlights
  • Jingyu Sake — Jingyu Sake is a sake brewing provider that specializes on the research, development, and application of strains and rice grinding technologies, with a commitment to the resuscitation of Chinese sake brands.
  • Magicpen Bio — Magicpen Bio is a crop seed manufacturer and seller that engages in scientific research and development of agriculture production.
  • Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.
Lenovo Capital and Incubator Group (LCIG) VC Fund · Beijing, Beijing, China · 23 investments in the past 12 months
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
  • Software, Artificial Intelligence, Manufacturing
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • Daimeng Robot — Daimeng Robot is dedicated to creating multi-series general-purpose humanoid robot products that are actually commercially available and concentrate on their research and production. It offers a comprehensive selection of goods and cutting-edge answers for situations including intelligent manufacturing, logistics, and commercial services.
  • Daimon Robotics — Daimon Robotics is a robotics company that specializes in the development and production of commercially viable general-purpose humanoid robot products with innovative intelligence.
  • Taifang Technology — ## Build Setup
ZhenFund VC Fund · Beijing, Beijing, China · 5 investments in the past 12 months
ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.
Show more
Investment focus
  • Artificial Intelligence, Software, E-Commerce
  • Series A, Seed, Series B
  • China, United States, Singapore
Portfolio highlights
  • UXLINK — UXLINK is a social infrastructure comprised of social protocols and a collection of Dapps.UXLINk creates groundbreaking landing sceneries for web3 groups.
  • Dianzhuo — Dianzhuo is a digital retail company that specializes in providing international and imported electrical appliances.
  • LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
LYFE Capital VC Fund · Shanghai, Shanghai, China · 3 investments in the past 12 months
In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • China, United States, France
Portfolio highlights
  • CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
  • ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Keio Innovation Initiative VC Fund · Tokyo, Tokyo, Japan · 7 investments in the past 12 months
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Funding Round, Seed, Series A
  • Japan
Portfolio highlights
  • elleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
  • NIHON AGRI — Exportation of Japanese agricultural products is currently small in volume. While Japanese farmers aspire to export their products to foreign countries for more people to enjoy and local consumers universally share the positive perception of the quality of Japanese agricultural products, issues such as price, communication, and logistics hinder theexpansion of exportation.They aim to solve these issues and satisfy the needs of both Japanese farmers and global consumers which are so clearly evident but devastatingly unmet.
  • Japan Carbon Cycle Lab — Japan Carbon Cycle Lab is a technology company that focuses on the research and development of CO2 capture and recycling techniques.
Oriental Fortune Capital VC Fund · Shenzhen, Guangdong, China · 7 investments in the past 12 months
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
  • Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
  • Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
Investors by industry
Investors by country
VC (Venture Capital) Funds in Asia by industry